A new article in Medical Marketing and Media discusses how the marketing of diabetes products could soon change as the American healthcare landscape transforms under new presidential leadership.
Some marketers see evidence that patients suffering with diabetes have already started benefiting from much of the disease-awareness campaigns, while other doubt it.
But with more patients being diagnosed with diabetes, only more ad dollars will be spent on advertising medications and treatments to them.
To read more about how diabetes treatments will be marketed differently going forward, follow the link below:
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.